Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - TOKEN COMMUNITIES LTD. | exhibit312_ex31z2.htm |
| EX-31.1 - EXHIBIT 31.1 - TOKEN COMMUNITIES LTD. | exhibit311_ex31z1.htm |
| 10-Q - FORM 10Q - TOKEN COMMUNITIES LTD. | extract9302017_10q.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Extract Pharmaceuticals , Inc. (the “ Company ” ), for the quarter ended September 30, 2017, as filed with the Securities and Exchange Commission (the “ Report ” ), the undersigned, Peter E. Maddocks , chief executive officer of the Company and chief financial officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
/s/ Peter E. Maddocks
Peter E. Maddocks
Chief Executive Officer and Chief Financial Officer
Dated: November 19, 2017